SynthesisMedicine2026
Risk factors for sudden cardiac death in heart failure: A systematic review and meta-analysis of risk factors derived from prediction models.
Synthesis in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundHeart failure (HF) is a global health burden with high mortality. Sudden cardiac death (SCD) remains a major complication, highlighting the need for accurate risk prediction.
methodsWe conducted a systematic review and meta-analysis, guided by the Population, Intervention, Comparator, Outcome, Timing, and Setting framework, to identify risk factors for SCD in HF and assess prediction models. Searches across 8 databases yielded eligible studies. Data extraction, risk of bias assessment using the Prediction Model Risk of Bias Assessment Tool, and statistical analyses were performed.
resultsTwelve studies met inclusion criteria, with 8 included in the meta-analysis. New York Heart Association classification and left ventricular ejection fraction emerged as the most robust predictors of SCD. Additional significant factors included age, sex, ischemic etiology, diabetes, heart rate, sodium, potassium, creatinine, estimated glomerular filtration rate, and hemoglobin. Considerable heterogeneity was observed among studies.
conclusionNew York Heart Association class and left ventricular ejection fraction are key predictors of SCD in HF, while demographic, etiological, and laboratory factors further refine risk assessment. Current models show limitations due to heterogeneity and lack of external validation. Future work should integrate refined predictors, treatment responses, and diverse populations to improve the accuracy and clinical utility of SCD risk stratification in HF.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.